about
Malignant hyperthermia and the clinical significance of type-1 ryanodine receptor gene (RYR1) variants: proceedings of the 2013 MHAUS Scientific Conference.From the Journal archives: hereditary aspects of malignant hyperthermia.The couplonopathies: A comparative approach to a class of diseases of skeletal and cardiac muscle.Can ultrasound of the tibial nerve detect diabetic peripheral neuropathy? A cross-sectional study.Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndromeMalignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.Round Table on Malignant Hyperthermia in Physically Active Populations: Meeting Proceedings.Neuromuscular conditions associated with malignant hyperthermia in paediatric patients: A 25-year retrospective study.Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review.Accuracy of malignant hyperthermia diagnoses in hospital discharge records.An Expedited Care Pathway with Ambulatory Brachial Plexus Analgesia Is a Cost-effective Alternative to Standard Inpatient Care after Complex Arthroscopic Elbow Surgery: A Randomized, Single-blinded Study.CASQ1 gene is an unlikely candidate for malignant hyperthermia susceptibility in the North American population.Malignant hyperthermia testing in probands with NO adverse anesthetic reaction.Effect of local anaesthetic volume (20 vs 5 ml) on the efficacy and respiratory consequences of ultrasound-guided interscalene brachial plexus block.Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.Malignant Hyperthermia Susceptibility and Related Diseases.Skeletal Muscle Metabolic Dysfunction in Patients With Malignant Hyperthermia Susceptibility.A Perioperative Smoking Cessation Intervention With Varenicline, Counseling, and Fax Referral to a Telephone Quitline Versus a Brief Intervention: A Randomized Controlled Trial.In Memoriam: Dr. Beverly Evans-Britt.A novel KCNA1 mutation in a family with episodic ataxia and malignant hyperthermia.Malignant hyperthermia testing in probands without adverse anesthetic reaction.Compound RYR1 heterozygosity resulting in a complex phenotype of malignant hyperthermia susceptibility and a core myopathy.Ultrasound provides a reliable test of local anesthetic spread.Confirmation of epidural catheter placement in a quadriplegic patient using a nerve stimulator.Case report: management of life-threatening oropharyngeal bleeding with recombinant factor VIIa.Updated guide for the management of malignant hyperthermia.Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic ReviewAbnormal calcium signalling and the caffeine-halothane contracture testIs malignant hyperthermia associated with hyperglycaemia?Fatal awake malignant hyperthermia episodes in a family with malignant hyperthermia susceptibility: a case seriesSafety of Chronic Cardiac Ryanodine Receptor Modulation: A 10-Year ExperienceIn replyMALIGNANT HYPERTHERMIA--AN UPDATE FOR PERIOPERATIVE NURSES
P50
Q34770934-427910F4-AE4A-4FDC-9CFD-E2499568A3DFQ35237956-F839D1A1-AC82-41BC-A293-52EFC143302DQ35642611-EEAA43F1-9751-4E3D-9D24-3EEA7BFAB3E4Q36426800-B71F1247-20E6-40F6-810B-DEED39C4E131Q37362266-9628E697-7657-440C-A755-83C5D48140D8Q38120619-9D475B41-224B-43BA-A689-1A5E978D45E6Q38692315-4B762317-724F-452F-8750-E20A73F1CA67Q38764315-7B5E11CA-A8C6-4F4F-98D4-0A6DC2E6471CQ38888258-C85A3219-2604-46E6-A898-2A6A5F7AD23EQ40188765-32DC3B61-8E90-4FF8-A0C1-AEF6281790B7Q40530996-93779660-3FFC-42AE-85A0-6A08CB697F1FQ43479454-8C8A82BF-A43D-4521-B345-F88953B88CC0Q46172685-957005EF-FA03-4EB3-AEC0-2B263C43861EQ46444347-99235843-26AC-4DE7-9C73-CCC72FF01780Q47253099-E20BB55C-E4FB-4F42-A5BD-28B31C7D5FCAQ47253117-1B803570-03C3-4D2E-99C4-1988DB0AC82AQ47277068-9E239DC0-D1E0-42D6-8D28-D3E666EE652CQ47317623-B94D5500-8954-4BB5-A92C-FF288968D903Q47361274-F3B80ABF-31A5-462C-9A59-F9E3980D3D19Q47422985-940D933B-9379-4D90-8F42-47D4AE4031CEQ47690617-FA9CA27F-6E6F-4DE0-87B7-44564D9CB806Q47707532-2253FE30-5041-4FBB-AF9D-F257F4699FFDQ48345516-165DE464-8C66-4B54-9B60-284CF98AC4CBQ48384237-2BD9E9EE-18BD-4CD6-9C7C-DDA1CCE18F8EQ48664538-65041CB1-B0F5-4B37-BA96-5286DF35F910Q52802400-6A968EFF-9965-4CD2-8663-56A30C509A70Q90496856-1B7C1CC5-3AB3-42D2-B9E2-7F037E5BC8FDQ90717797-D19B350C-38EA-4535-8EC2-5D4E78BD5EF8Q90717865-15AB0B31-86C3-4E0E-87B8-9340E1C3D6D4Q91918501-5C23DA1F-3859-473E-B017-311A692E0829Q93356079-FD6A14D1-2183-45EB-ACBB-C640A04A1793Q95423325-BCC01E13-E6BA-43E5-ACF6-7B5071DEABE7Q95542981-FCE9EE69-F3DE-44DD-A6ED-9AB884A110E6
P50
description
onderzoeker
@nl
researcher
@en
researcher
@en-gb
հետազոտող
@hy
name
Sheila Riazi
@ast
Sheila Riazi
@en
Sheila Riazi
@en-gb
Sheila Riazi
@es
Sheila Riazi
@nl
Sheila Riazi
@sl
type
label
Sheila Riazi
@ast
Sheila Riazi
@en
Sheila Riazi
@en-gb
Sheila Riazi
@es
Sheila Riazi
@nl
Sheila Riazi
@sl
prefLabel
Sheila Riazi
@ast
Sheila Riazi
@en
Sheila Riazi
@en-gb
Sheila Riazi
@es
Sheila Riazi
@nl
Sheila Riazi
@sl
P106
P1153
14625514300
P31
P496
0000-0002-0670-1516